✦ LIBER ✦

IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patients

✍ Scribed by B. Schilling, E. S. Halstead, P. Schuler, M. Harasymczuk, J. E. Egan, T. L. Whiteside

Book ID: 118781344
Publisher: Springer-Verlag
Year: 2012
Tongue: English
Weight: 515 KB
Volume: 61
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-011-1197-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

IL-2- or IL-15-activated NK cells enhanc

IL-2- or IL-15-activated NK cells enhance Cetuximab-mediated activity against triple-negative breast cancer in xenografts and in breast cancer patients

✍ María P. Roberti, Yamila S. Rocca, Mora Amat, María B. Pampena, José Loza, Feder 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 756 KB

Enhancement of natural killer cell activ

Enhancement of natural killer cell activity and 2-5A synthetase in operable breast cancer patients treated with polyadenylic; polyuridylic acid

✍ Ara G. Hovanessian; Jung Koo Youn; Claudine Buffet-Janvresse; Yves Riviere; Mich 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 618 KB

A Novel Histone Deacetylase Inhibitor, S

A Novel Histone Deacetylase Inhibitor, Scriptaid, Enhances Expression of Functional Estrogen Receptor α (ER) in ER negative human breast cancer cells in combination with 5-aza 2′-deoxycytidine

✍ Judith Clancy Keen; Lan Yan; Kelly M. Mack; Catherine Pettit; Dawn Smith; Dipali 📂 Article 📅 2003 🏛 Springer US 🌐 English ⚖ 481 KB

First-in-man application of a novel ther

First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients

✍ Neil L Berinstein, Mohan Karkada, Michael A Morse, John J Nemunaitis, Gurkamal C 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 269 KB

CD80 expression in an HLA-A2-positive hu

CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer

✍ Dale L. Bixby; John R. Yannelli 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 185 KB 👁 2 views

To generate non-small cell lung cancer (NSCLC)-reactive lymphocytes, we transfected an HLA-A2-expressing human NSCLC line (1355) with the cDNA encoding the lymphocyte co-stimulatory molecule CD80. Following selection in G418, 1355.7 demonstrated stable cell-surface expression of CD80. Allogeneic mix

A Novel Antisense Oligonucleotide Inhibi

A Novel Antisense Oligonucleotide Inhibiting Several Antiapoptotic Bcl-2 Family Members Induces Apoptosis and Enhances Chemosensitivity in Androgen-Independent Human Prostate Cancer PC3 Cells

✍ Andriole, G.L. 📂 Article 📅 2006 🏛 Elsevier Science ⚖ 54 KB